Why is Sandu Pharmaceuticals Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 3.73%
- Poor long term growth as Net Sales has grown by an annual rate of 1.97% and Operating profit at 1.01% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.92
2
Flat results in Sep 26
- DPS(Y) Lowest at Rs 0.00
- DPR(Y) Lowest at 0.00%
3
Stock is technically in a Bearish range
- The technical trend has deteriorated from Mildly Bearish on 20-Nov-26
- Multiple factors for the stock are Bearish like RSI, MACD, Bollinger Band and KST
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -15.01% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Sandu Pharma. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Sandu Pharma.
-15.01%
-0.29
51.08%
Sensex
-2.0%
-0.13
14.98%
Quality key factors
Factor
Value
Sales Growth (5y)
1.97%
EBIT Growth (5y)
1.01%
EBIT to Interest (avg)
1.92
Debt to EBITDA (avg)
0.14
Net Debt to Equity (avg)
-0.05
Sales to Capital Employed (avg)
1.63
Tax Ratio
27.91%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
4.94%
ROE (avg)
3.73%
Valuation Key Factors 
Factor
Value
P/E Ratio
22
Industry P/E
19
Price to Book Value
0.82
EV to EBIT
15.54
EV to EBITDA
11.76
EV to Capital Employed
0.81
EV to Sales
0.48
PEG Ratio
0.88
Dividend Yield
2.80%
ROCE (Latest)
5.22%
ROE (Latest)
3.71%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
Technical Movement
4What is working for the Company
OPERATING CF(Y)
Highest at Rs 6.12 Cr
NET SALES(Q)
Highest at Rs 19.43 cr
-2What is not working for the Company
DPS(Y)
Lowest at Rs 0.00
DPR(Y)
Lowest at 0.00%
Loading Valuation Snapshot...
Here's what is working for Sandu Pharma.
Operating Cash Flow - Annually
Highest at Rs 6.12 Cr and Grown
each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (Rs Cr)
Net Sales - Quarterly
Highest at Rs 19.43 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Here's what is not working for Sandu Pharma.
Dividend per Share (DPS) - Annually
Lowest at Rs 0.00
in the last five yearsMOJO Watch
Company is distributing lower dividend than previous years
DPS (Rs)
Dividend Payout Ratio (DPR) - Annually
Lowest at 0.00%
in the last five yearsMOJO Watch
Company is distributing lower proportion of profits generated as dividend
DPR (%)